1. Efficacy and safety of Xiaoaiping combined with chemotherapy in the treatment of advanced esophageal cancer
Feng WANG ; Qingxia FAN ; Honghai WANG ; Dongmei HAN ; Nasha SONG ; Hong LU
Chinese Journal of Oncology 2017;39(6):453-457
Objective:
To evaluate the efficacy and safety of Xiaoaiping combined with chemotherapy in the treatment of advanced esophageal cancer.
Methods:
This is a multi-center, randomized, open label and parallel controlled study. A total of 124 advanced esophageal cancer patients with Karnofsky Performance Status (KPS) score ≥60 and expected survival time≥3 months were enrolled. We adopted design and divided the patients into study and control group. The patients in study group received Xiaoaiping combined with S-1 and cisplatin. The control group received S-1 and cisplatin. Each group included 62 patients and 21 days as a treatment cycle. The efficacy and adverse events in patients of the two groups were observed and compared.
Results:
57 patients in the study group and 55 in the control group were included in efficacy assessment. The response rate was 54.4% and 34.5% in the study group and control group, respectively(